Richard Newcomb Stillwell bought $58k of TNXP
director at Tonix Pharmaceuticals Holding Corp.. 5,000 shares at an average of $11.65, traded Jun 8, 2026, filed Jun 9, 2026.
Score components
- +15RoleDirector
- +7Trade size$58k at market
- +8Relative to holdingsFirst purchase: no shares before this trade
- +18Price context6% above the 52-week low; 81% below the 52-week high
- +15Cluster3 insiders buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001493152-26-027985, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jun 8, 2026 | POpen-market purchase Common Stock, $0.001 par value | +5,000 | $11.65 | $58k | 5,000 | Jun 9, 2026 |
Related signals
Other insiders at Tonix Pharmaceuticals Holding Corp. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 57Moderate | Tonix Pharmaceuticals Holding Corp. | Seth Lederman Chief Executive Officer | $28k 2,000 shares | +22% | |
| 39Weak | Tonix Pharmaceuticals Holding Corp. | Richard H Bagger director | $13k 1,000 shares | - | |
| 58Moderate | Tonix Pharmaceuticals Holding Corp. | Carolyn E. Taylor director | $15k 1,415 shares | +339% | |
| 80Strong | Tonix Pharmaceuticals Holding Corp. | Seth Lederman Chief Executive Officer | $59k 5,000 shares | +125% | |
| 52Moderate | TNXPbuy Tonix Pharmaceuticals Holding Corp. | Seth Lederman Chief Executive Officer | $63k 5,000 shares | +33% | |
| 65Notable | TNXPbuy Tonix Pharmaceuticals Holding Corp. | Seth Lederman Chief Executive Officer | $223k 15,000 shares | first purchase | |
| 31Weak | Tonix Pharmaceuticals Holding Corp. | Carolyn E. Taylor director | $15k 418 shares | - | |
| 31Weak | Tonix Pharmaceuticals Holding Corp. | James Treco director | $9,000 250 shares | - | |
| 44Moderate | TNXPbuy Tonix Pharmaceuticals Holding Corp. | Seth Lederman Chief Executive Officer | $86k 4,000 shares | first purchase |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.